Symbol="RVMD"
AssetType="Common Stock"
Name="Revolution Medicines Inc"
Description="Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California."
CIK="1628171"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="700 SAGINAW DR, REDWOOD CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="3188327000"
EBITDA="-317656992"
PERatio="None"
PEGRatio="None"
BookValue="8.53"
DividendPerShare="0"
DividendYield="0"
EPS="-2.9"
RevenuePerShareTTM="0.314"
ProfitMargin="0"
OperatingMarginTTM="-10.91"
ReturnOnAssetsTTM="-0.236"
ReturnOnEquityTTM="-0.414"
RevenueTTM="29524000"
GrossProfitTTM="-217693000"
DilutedEPSTTM="-2.9"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.581"
AnalystTargetPrice="35.2"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="72.24"
PriceToBookRatio="3.162"
EVToRevenue="53.04"
EVToEBITDA="-6.63"
Beta="1.43"
num_52WeekHigh="33.19"
num_52WeekLow="17.03"
num_50DayMovingAverage="26.89"
num_200DayMovingAverage="24.46"
SharesOutstanding="106313000"
DividendDate="None"
ExDividendDate="None"
symbol="RVMD"
open="29.54"
high="30.14"
low="29.54"
price="29.99"
volume="500614.00"
latest_trading_day="2023-08-11"
previous_close="29.81"
change="0.18"
change_percent="0.6038%"
aroon_positive_momentum_days="54"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="54"
Volume_recent_avg="1000682"
Change_recent_avg="0.09"
Delta_recent_avg="1.1"
Variance_recent_avg="0.55"
Change_ratio_recent_avg="0.29"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="54"
Aroon_momentum_negative="46"
image_negative_thumbnail_id_1="518"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0087.jpeg"
image_negative_thumbnail_id_2="514"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0091.jpeg"
image_neutral_thumbnail_id_1="527"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0072.jpeg"
image_neutral_thumbnail_id_2="597"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0002.jpeg"
image_positive_thumbnail_id_1="694"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0014.jpeg"
image_positive_thumbnail_id_2="650"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0058.jpeg"
image_professor_thumbnail_id_1="1168"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
image_professor_thumbnail_id_2="1199"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
